IND
LAVA-051 consists of two single domain antibodies linked via a short five amino acid glycine-serine linker.
The phase I/II study will assess the safety and tolerability of the drug.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.